Table 2 Determinants of unfavorable treatment outcome at 60 months among those active in treatment at month six
Variable | Sub-category | Hazard ratio, crude | P- value | Hazard ratio, adj | P-value |
|---|---|---|---|---|---|
Age | <15 | 1 | 1 | ||
≥15 | 1.6 | 0.001 | 1.6 | 0.002 | |
Gender | Female | 1 | 1 | ||
Male | 1.3 | <0.001 | 1.2 | <0.001 | |
Baseline WHO Stage | I or II | 1 | 1 | ||
III or IV | 1.5 | <0.001 | 1.4 | <0.001 | |
Baseline CD4 | <100 | 1 | 1 | ||
100–349 | 0.7 | <0.001 | 0.8 | <0.001 | |
≥350 | 0.8 | 0.008 | 0.9 | 0.106 | |
Ever discontinued HAART before 6 months | No | 1 | 1 | ||
Yes | 1.8 | 0.000 | 1.9 | 0.000 |